Search results

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The Nobel Prizes for Physics, Chemistry and Medicine have been announced. 

A groundbreaking international study has provided new insights into global fossil methane emissions, using innovative multi-isotopic atmospheric measurements.  

Timetable and Teams links

Detailed data on ANSTO electricity use and CO2 emissions for FY2024 - FY2025

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.

Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub

The Australian Critical Minerals Research and Development Hub (the Hub) unites the expertise of top Federal science agencies: ANSTO, Geoscience Australia, and CSIRO with the aim of addressing technical challenges and drive collaborative research across the critical minerals value chain.

The Medium Energy- X-ray Absorption Spectroscopy beamlines provides access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.